Zoetis Inc. $ZTS Shares Purchased by Narwhal Capital Management

Narwhal Capital Management boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 276.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 15,859 shares of the company’s stock after acquiring an additional 11,644 shares during the period. Narwhal Capital Management’s holdings in Zoetis were worth $2,320,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in ZTS. Nova Wealth Management Inc. purchased a new stake in shares of Zoetis during the first quarter worth approximately $25,000. Halbert Hargrove Global Advisors LLC grew its holdings in Zoetis by 496.6% during the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares in the last quarter. REAP Financial Group LLC grew its holdings in Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares in the last quarter. NewSquare Capital LLC increased its position in shares of Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after purchasing an additional 85 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in shares of Zoetis in the 1st quarter valued at $35,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Bank of America downgraded shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a research note on Monday, December 15th. Barclays initiated coverage on shares of Zoetis in a research report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. Stifel Nicolaus dropped their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research report on Thursday, December 18th. Finally, HSBC set a $140.00 target price on Zoetis in a research note on Wednesday, December 10th. Six equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Zoetis has an average rating of “Hold” and a consensus target price of $160.18.

Zoetis Stock Performance

Shares of ZTS opened at $127.10 on Friday. Zoetis Inc. has a 12-month low of $115.25 and a 12-month high of $177.40. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. The company has a 50-day moving average of $123.29 and a two-hundred day moving average of $140.72. The stock has a market cap of $56.01 billion, a P/E ratio of 21.40, a PEG ratio of 2.58 and a beta of 0.97.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the prior year, the firm earned $1.58 EPS. Zoetis’s quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio (DPR) is 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.